Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects

Metabolism: Clinical and Experimental

Volumn 47, Issue 6, 1998, Pages 686-689

  Fonseca, Vivian A ^a   Mudaliar, Sunder ^b   Schmidt, B ^b   Fink, Louis M ^b   Kern, Philip A ^b   Henry, Robert R ^b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; INSULIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INSULIN RESPONSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031781803     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90031-2     Document Type: Article

References (15)

1. Guba S, Fonseca V, Fink L: Hyperhomocysteinemia - The emerging and important risk factor for cardiovascular disease. Am J Clin Pathol 106:709-722, 1996
2. Munshi M, Stone A, Fink L, et al: Hyperhomocysteinemia following a methionine load in non-insulin-dependent diabetes and macrovascular disease. Metabolism 45:133-135, 1996
3. Araki A, Sako Y, Ito H: Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: Effect of parenteral methylcobalamin treatment. Atherosclerosis 103:149-157, 1993
4. Hoogeveen E, Heine R, Kostense P, et al: Increased risk for cardiovascular disease by high homocysteine is related to glucose tolerance: The Hoorn Study. Diabetes 46:25A, 1997 (suppl 1, abstr)
5. Stern MP: Diabetes and cardiovascular disease, the "common soil" hypothesis. Diabetes 44:369-374, 1995
6. Steinberg HO, Chaker H, Learning R, et al: Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610, 1996
7. Trovati M, Mularoni EM, Burzacca S, et al: Imaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients. Diabetes 44:1318-1322, 1995
8. Flakoll P, Carlson MG, Cherrington A: Physiologic action of insulin, in LeRoith D, Taylor SI, Olefsky JM (eds): Diabetes Mellitus, a Fundamental and Clinical Text. Philadelphia, PA, Lippincott-Raven, 1996, pp 121-132
9. Ubbink JB, Vermaak WJH, Bissbort S: Rapid high-performance liquid Chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441-446, 1991
10. McGuire EAH, Helderman JH, Tobin JD, et al: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
11. Molina JM, Baron AD, Edelman SV, et al: Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol 258:E16-E23, 1990
12. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic clamps: Comparisons of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
13. 35 methionine. J Biol Chem 188:37-48, 1951
14. Zinneman HH, Nuttall FQ, Goetz FC: Effect of endogenous insulin on human amino acid metabolism. Diabetes 15:5-8, 1966
15. Swendseid ME, Tuttle SG, Drenick EJ, et al: Plasma amino acid response to glucose administration in various nutritive states. Am J Clin Nutr 20:243-249, 1967